Clinical trial data published since 2021 has consistently demonstrated significant HbA1c reduction and weight loss with semaglutide compared to other GLP-1 receptor agonists
Heres a look at the differences: Learn more: Liraglutide vs
However, it is not fully understood how obesity parameters affect the progression of coronary artery calcification (CAC) in Korean population
Yet this advantage disappears if the drug cannot reach adequate blood concentrations in the first place
Ozempic is FDA-approved for: Controlling blood sugar in adults with type 2 diabetes Reducing the risk of serious heart problems, like heart attack, stroke, and death, in adults with type 2 diabetes and heart disease Reducing the risk of worsening kidney disease and cardiovascular deaths in adults with type 2 diabetes and chronic kidney disease Although Ozempic isnt FDA-approved for weight loss, a healthcare provider may prescribe it off-label to help with weight management
When considering the timeline of GLP-1 medication, its helpful to remember that progress is gradual